Bill Ackman Supports Valeant’s Allergan Offer

Bill Ackman Supports Valeant’s Allergan Offer Play

April 22 (Bloomberg) -- Valeant Pharmaceuticals International offered to buy Allergan in a cash-and-stock deal valued at $45.7 billion that will give the Canadian company the Botox wrinkle treatment. Pershing Square Capital Management LP, the fund run by Bill Ackman, Allergan’s largest shareholder, supports the offer, Valeant said. Stephanie Ruhle reports on Bloomberg Television’s “In The Loop.” (Source: Bloomberg)

  • On Air Now

    In The Loop with Betty Liu Watch Now

  • Next

    Market Makers

blog comments powered by Disqus